Comprehensive Stock Comparison
Compare Universal Health Realty Income Trust (UHT) vs Ardent Health Partners, LLC (ARDT) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | ARDT | 10.3% revenue growth vs UHT's -100.0% |
| Value | ARDT | Lower P/E (7.4x vs 25.2x) |
| Quality / Margins | UHT | 11.8% net margin vs ARDT's 3.2% |
| Stability / Safety | UHT | Beta 0.24 vs ARDT's 0.88 |
| Dividends | UHT | 6.8% yield; 14-year raise streak; ARDT pays no meaningful dividend |
| Momentum (1Y) | UHT | +16.7% vs ARDT's -35.9% |
| Efficiency (ROA) | ARDT | 4.0% ROA vs UHT's 3.1% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Universal Health Realty Income Trust is a healthcare-focused real estate investment trust that owns and leases medical facilities including hospitals, rehabilitation centers, and medical office buildings. It generates revenue primarily through long-term triple-net leases — collecting rent from healthcare operators who cover property expenses — with its portfolio spanning 71 properties across 20 states. The trust's competitive advantage lies in its specialized healthcare real estate expertise and stable tenant base of established healthcare providers in recession-resistant medical facilities.
Ardent Health Partners operates a network of acute care hospitals and clinics providing comprehensive healthcare services across the United States. It generates revenue primarily from patient care services — including inpatient and outpatient treatments, surgeries, and rehabilitation — with the majority coming from government and private insurance reimbursements. The company benefits from its regional concentration in key markets, which creates operational efficiencies and strong local physician relationships that drive patient referrals.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
UHT leads in 4 of 6 categories (Financial Metrics, Total Returns). ARDT leads in 2 (Valuation Metrics, Profitability & Efficiency).
Financial Metrics (TTM)
ARDT is the larger business by revenue, generating $6.3B annually — 42.5x UHT's $149M. UHT is the more profitable business, keeping 11.8% of every revenue dollar as net income compared to ARDT's 3.2%. On growth, UHT holds the edge at +2.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | UHTUniversal Health … | ARDTArdent Health Par… |
|---|---|---|
| RevenueTrailing 12 months | $149M | $6.3B |
| EBITDAEarnings before interest/tax | $83M | $948M |
| Net IncomeAfter-tax profit | $18M | $205M |
| Free Cash FlowCash after capex | $59M | $155M |
| Gross MarginGross profit ÷ Revenue | +94.4% | +70.6% |
| Operating MarginEBIT ÷ Revenue | +36.3% | +12.6% |
| Net MarginNet income ÷ Revenue | +11.8% | +3.2% |
| FCF MarginFCF ÷ Revenue | +40.0% | +2.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.0% | +8.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -5.9% | -189.5% |
Valuation Metrics
At 5.9x trailing earnings, ARDT trades at a 83% valuation discount to UHT's 34.3x P/E. On an enterprise value basis, ARDT's 5.6x EV/EBITDA is more attractive than UHT's 20.7x.
| Metric | UHTUniversal Health … | ARDTArdent Health Par… |
|---|---|---|
| Market CapShares × price | $605M | $1.3B |
| Enterprise ValueMkt cap + debt − cash | $599M | $3.1B |
| Trailing P/EPrice ÷ TTM EPS | 34.35x | 5.94x |
| Forward P/EPrice ÷ next-FY EPS est. | 25.21x | 7.38x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.08x |
| EV / EBITDAEnterprise value multiple | 20.74x | 5.55x |
| Price / SalesMarket cap ÷ Revenue | — | 0.22x |
| Price / BookPrice ÷ Book value/share | 3.97x | 0.82x |
| Price / FCFMarket cap ÷ FCF | 12.33x | 10.51x |
Profitability & Efficiency
ARDT delivers a 12.6% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $12 for UHT. On the Piotroski fundamental quality scale (0–9), ARDT scores 8/9 vs UHT's 3/9, reflecting strong financial health.
| Metric | UHTUniversal Health … | ARDTArdent Health Par… |
|---|---|---|
| ROE (TTM)Return on equity | +11.6% | +12.6% |
| ROA (TTM)Return on assets | +3.1% | +4.0% |
| ROICReturn on invested capital | — | +9.7% |
| ROCEReturn on capital employed | — | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 8 |
| Debt / EquityFinancial leverage | — | 1.50x |
| Net DebtTotal debt minus cash | -$7M | $1.7B |
| Cash & Equiv.Liquid assets | $7M | $557M |
| Total DebtShort + long-term debt | $0 | $2.3B |
| Interest CoverageEBIT ÷ Interest expense | — | 7.08x |
Total Returns (with DRIP)
A $10,000 investment in UHT five years ago would be worth $9,261 today (with dividends reinvested), compared to $5,847 for ARDT. Over the past 12 months, UHT leads with a +16.7% total return vs ARDT's -35.9%. The 3-year compound annual growth rate (CAGR) favors UHT at -0.4% vs ARDT's -16.4% — a key indicator of consistent wealth creation.
| Metric | UHTUniversal Health … | ARDTArdent Health Par… |
|---|---|---|
| YTD ReturnYear-to-date | +11.1% | +8.7% |
| 1-Year ReturnPast 12 months | +16.7% | -35.9% |
| 3-Year ReturnCumulative with dividends | -1.2% | -41.5% |
| 5-Year ReturnCumulative with dividends | -7.4% | -41.5% |
| 10-Year ReturnCumulative with dividends | +37.8% | -41.5% |
| CAGR (3Y)Annualised 3-year return | -0.4% | -16.4% |
Risk & Volatility
UHT is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than ARDT's 0.88 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UHT currently trades 97.6% from its 52-week high vs ARDT's 60.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | UHTUniversal Health … | ARDTArdent Health Par… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.24x | 0.88x |
| 52-Week HighHighest price in past year | $44.70 | $15.55 |
| 52-Week LowLowest price in past year | $35.26 | $8.07 |
| % of 52W HighCurrent price vs 52-week peak | +97.6% | +60.4% |
| RSI (14)Momentum oscillator 0–100 | 70.1 | 55.7 |
| Avg Volume (50D)Average daily shares traded | 59K | 341K |
Analyst Outlook
UHT is the only dividend payer here at 6.78% yield — a key consideration for income-focused portfolios.
| Metric | UHTUniversal Health … | ARDTArdent Health Par… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $14.57 |
| # AnalystsCovering analysts | — | 12 |
| Dividend YieldAnnual dividend ÷ price | +6.8% | — |
| Dividend StreakConsecutive years of raises | 14 | 1 |
| Dividend / ShareAnnual DPS | $2.96 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Aug 24 | Feb 26 | Change |
|---|---|---|---|
| Universal Health Re… (UHT) | 100 | 94.35 | -5.6% |
| Ardent Health Partn… (ARDT) | 111.89 | 53.49 | -52.2% |
Universal Health Re… (UHT) returned -7% over 5 years vs Ardent Health Partn… (ARDT)'s -42%.
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Universal Health Re… (UHT) | $67M | $0.00 | -100.0% |
| Ardent Health Partn… (ARDT) | $2.1B | $6.0B | +183.4% |
Universal Health Realty Income Trust's revenue grew from $67M (2016) to $0M (2025) — a -100.0% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2015 | 2024 | Change |
|---|---|---|---|
| Universal Health Re… (UHT) | 37.0% | 19.4% | -47.6% |
| Ardent Health Partn… (ARDT) | 0.7% | 3.5% | +408.3% |
Universal Health Realty Income Trust's net margin went from 37% (2015) to 19% (2024).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Universal Health Re… (UHT) | 22.4 | 30.9 | +37.9% |
Universal Health Realty Income Trust has traded in a 8x–85x P/E range over 9 years; current trailing P/E is ~34x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Universal Health Re… (UHT) | 1.28 | 1.27 | -0.8% |
| Ardent Health Partn… (ARDT) | 0.1 | 1.58 | +1480.0% |
Universal Health Realty Income Trust's EPS grew from $1.28 (2016) to $1.27 (2025) — a -0% CAGR.
Chart 6Free Cash Flow — 5 Years
Universal Health Realty Income Trust generated $49M FCF in 2025 (+41% vs 2021). Ardent Health Partners, LLC generated $128M FCF in 2024 (+167% vs 2022).
UHT vs ARDT: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is UHT or ARDT a better buy right now?
Ardent Health Partners, LLC (ARDT) offers the better valuation at 5.9x trailing P/E (7.4x forward), making it the more compelling value choice. Analysts rate Ardent Health Partners, LLC (ARDT) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — UHT or ARDT?
On trailing P/E, Ardent Health Partners, LLC (ARDT) is the cheapest at 5.9x versus Universal Health Realty Income Trust at 34.3x. On forward P/E, Ardent Health Partners, LLC is actually cheaper at 7.4x.
03Which is the better long-term investment — UHT or ARDT?
Over the past 5 years, Universal Health Realty Income Trust (UHT) delivered a total return of -7.4%, compared to -41.5% for Ardent Health Partners, LLC (ARDT). A $10,000 investment in UHT five years ago would be worth approximately $9K today (assuming dividends reinvested). Over 10 years, the gap is even starker: UHT returned +37.8% versus ARDT's -41.5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — UHT or ARDT?
By beta (market sensitivity over 5 years), Universal Health Realty Income Trust (UHT) is the lower-risk stock at 0.24β versus Ardent Health Partners, LLC's 0.88β — meaning ARDT is approximately 267% more volatile than UHT relative to the S&P 500.
05Which has better profit margins — UHT or ARDT?
Universal Health Realty Income Trust (UHT) is the more profitable company, earning 11.8% net margin versus 3.5% for Ardent Health Partners, LLC — meaning it keeps 11.8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UHT leads at 36.3% versus 6.8% for ARDT. At the gross margin level — before operating expenses — UHT leads at 94.4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is UHT or ARDT more undervalued right now?
On forward earnings alone, Ardent Health Partners, LLC (ARDT) trades at 7.4x forward P/E versus 25.2x for Universal Health Realty Income Trust — 17.8x cheaper on a one-year earnings basis.
07Which pays a better dividend — UHT or ARDT?
In this comparison, UHT (6.8% yield) pays a dividend. ARDT does not pay a meaningful dividend and should not be held primarily for income.
08Is UHT or ARDT better for a retirement portfolio?
For long-horizon retirement investors, Universal Health Realty Income Trust (UHT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.24), 6.8% yield). Both have compounded well over 10 years (UHT: +37.8%, ARDT: -41.5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between UHT and ARDT?
These companies operate in different sectors (UHT (Real Estate) and ARDT (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced. In terms of investment character: UHT is a small-cap income-oriented stock; ARDT is a small-cap deep-value stock. UHT pays a dividend while ARDT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.